SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-018200
Filing Date
2020-04-23
Accepted
2020-04-23 16:16:27
Documents
51
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q toca-10q_20200331.htm 10-Q 1116246
2 EX-31.1 toca-ex311_7.htm EX-31.1 16333
3 EX-31.2 toca-ex312_6.htm EX-31.2 16194
4 EX-32.1 toca-ex321_8.htm EX-32.1 6488
  Complete submission text file 0001564590-20-018200.txt   3781275

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT toca-20200331.xml EX-101.INS 652861
6 XBRL TAXONOMY EXTENSION SCHEMA toca-20200331.xsd EX-101.SCH 34821
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE toca-20200331_cal.xml EX-101.CAL 35316
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE toca-20200331_def.xml EX-101.DEF 104774
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE toca-20200331_lab.xml EX-101.LAB 277805
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE toca-20200331_pre.xml EX-101.PRE 204054
Mailing Address 4242 CAMPUS POINT COURT, SUITE 500 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 500 SAN DIEGO CA 92121 (858) 412-8400
Tocagen Inc (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38052 | Film No.: 20811201
SIC: 2834 Pharmaceutical Preparations